These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23732943)

  • 1. Recent approaches for the synthesis of modified cryptophycins.
    Weiss C; Sammet B; Sewald N
    Nat Prod Rep; 2013 Jul; 30(7):924-40. PubMed ID: 23732943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient synthesis of cryptophycin-52 and novel para-alkoxymethyl unit A analogues.
    Eissler S; Bogner T; Nahrwold M; Sewald N
    Chemistry; 2009 Oct; 15(42):11273-87. PubMed ID: 19760734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient and versatile stereoselective synthesis of cryptophycins.
    Mast CA; Eissler S; Stoncius A; Stammler HG; Neumann B; Sewald N
    Chemistry; 2005 Aug; 11(16):4667-77. PubMed ID: 15915529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of a new class of cryptophycins based tubulin inhibitors.
    Kumar A; Kumar M; Sharma S; Guru SK; Bhushan S; Shah BA
    Eur J Med Chem; 2015 Mar; 93():55-63. PubMed ID: 25647428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approaches for the synthesis of functionalized cryptophycins.
    Sammet B; Bogner T; Nahrwold M; Weiss C; Sewald N
    J Org Chem; 2010 Oct; 75(20):6953-60. PubMed ID: 20857920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptophycins: cytotoxic cyclodepsipeptides with potential for tumor targeting.
    Weiss C; Figueras E; Borbely AN; Sewald N
    J Pept Sci; 2017 Jul; 23(7-8):514-531. PubMed ID: 28661555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total synthesis of cryptophycin analogues via a scaffold approach.
    McCubbin JA; Maddess ML; Lautens M
    Org Lett; 2006 Jul; 8(14):2993-6. PubMed ID: 16805535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptophycins: a novel class of potent antimitotic antitumor depsipeptides.
    Shih C; Teicher BA
    Curr Pharm Des; 2001 Sep; 7(13):1259-76. PubMed ID: 11472266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosynthetic characterization and chemoenzymatic assembly of the cryptophycins. Potent anticancer agents from cyanobionts.
    Magarvey NA; Beck ZQ; Golakoti T; Ding Y; Huber U; Hemscheidt TK; Abelson D; Moore RE; Sherman DH
    ACS Chem Biol; 2006 Dec; 1(12):766-79. PubMed ID: 17240975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three new cryptophycins from Nostoc sp. GSV 224.
    Subbaraju GV; Golakoti T; Patterson GM; Moore RE
    J Nat Prod; 1997 Mar; 60(3):302-5. PubMed ID: 9090872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjugates of modified cryptophycins and RGD-peptides enter target cells by endocytosis.
    Nahrwold M; Weiß C; Bogner T; Mertink F; Conradi J; Sammet B; Palmisano R; Royo Gracia S; Preuße T; Sewald N
    J Med Chem; 2013 Mar; 56(5):1853-64. PubMed ID: 23387527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and structure determination of cryptophycins 38, 326, and 327 from the terrestrial cyanobacterium Nostoc sp. GSV 224.
    Chaganty S; Golakoti T; Heltzel C; Moore RE; Yoshida WY
    J Nat Prod; 2004 Aug; 67(8):1403-6. PubMed ID: 15332864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cryptophycins: their synthesis and anticancer activity.
    Eggen M; Georg GI
    Med Res Rev; 2002 Mar; 22(2):85-101. PubMed ID: 11857635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptophycins-309, 249 and other cryptophycin analogs: preclinical efficacy studies with mouse and human tumors.
    Liang J; Moore RE; Moher ED; Munroe JE; Al-awar RS; Hay DA; Varie DL; Zhang TY; Aikins JA; Martinelli MJ; Shih C; Ray JE; Gibson LL; Vasudevan V; Polin L; White K; Kushner J; Simpson C; Pugh S; Corbett TH
    Invest New Drugs; 2005 Jun; 23(3):213-24. PubMed ID: 15868377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Versatile Chemoenzymatic Synthesis for the Discovery of Potent Cryptophycin Analogs.
    Schmidt JJ; Khatri Y; Brody SI; Zhu C; Pietraszkiewicz H; Valeriote FA; Sherman DH
    ACS Chem Biol; 2020 Feb; 15(2):524-532. PubMed ID: 31961651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and cytotoxicity studies of new cryptophycin analogues.
    Liu WL; Zhang JC; Jiang FQ; Fu L
    Arch Pharm (Weinheim); 2009 Oct; 342(10):577-83. PubMed ID: 19714674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the cryptophycin P450 epoxidase reveals substrate tolerance and cooperativity.
    Ding Y; Seufert WH; Beck ZQ; Sherman DH
    J Am Chem Soc; 2008 Apr; 130(16):5492-8. PubMed ID: 18366166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total synthesis and antitubulin activity of c10 analogues of cryptophycin-24.
    Buck SB; Huff JK; Himes RH; Georg GI
    J Med Chem; 2004 Jan; 47(3):696-702. PubMed ID: 14736249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of the antimitotic peptide and depsipeptide binding site on beta-tubulin.
    Mitra A; Sept D
    Biochemistry; 2004 Nov; 43(44):13955-62. PubMed ID: 15518544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bridging the maytansine and vinca sites: Cryptophycins target β-tubulin's T5-loop.
    Abel AC; Mühlethaler T; Dessin C; Schachtsiek T; Sammet B; Sharpe T; Steinmetz MO; Sewald N; Prota AE
    J Biol Chem; 2024 Jun; 300(6):107363. PubMed ID: 38735475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.